Santosh Ghosh

Title: Innovations of Santosh Ghosh in Epithelial Cancer Detection

Introduction

Santosh Ghosh is an accomplished inventor based in Mayfield Heights, OH (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of epithelial cancer. With a total of 3 patents, his work is paving the way for advancements in cancer evaluation methods.

Latest Patents

One of Santosh Ghosh's latest patents focuses on a method for detecting epithelial cancer using beta defensin. This method includes several steps: first, determining the levels of beta defensin 3 (BD-3) and beta defensin 2 (BD-2) in a suspect sample obtained from a subject. Next, the level of BD-3 is compared to BD-2 to obtain a suspect BD-3/BD-2 ratio. This ratio is then compared to a healthy BD-3/BD-2 ratio to derive a diagnostic BD-3/BD-2 ratio. Finally, if the diagnostic BD-3/BD-2 ratio is greater than 1, the subject is characterized as having epithelial cancer. Additionally, a microfluidic device for detecting epithelial cancer using the diagnostic BD-3/BD-2 ratio is also described in his patent.

Career Highlights

Santosh Ghosh is affiliated with Case Western Reserve University, where he continues to innovate and contribute to research in cancer diagnostics. His work is instrumental in enhancing the accuracy and efficiency of cancer detection methods.

Collaborations

Some of his notable coworkers include Aaron Weinberg and Umut Atakan Gurkan, who collaborate with him on various research projects.

Conclusion

Santosh Ghosh's innovative approaches to epithelial cancer detection are making a significant impact in the medical field. His patents and ongoing research are crucial for improving diagnostic techniques and ultimately enhancing patient care.